Standout Papers

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6):... 2012 2026 2016 2021 451
  1. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study (2012)
    John B. Buse, Michael A. Nauck et al. The Lancet

Citation Impact

1 from Science/Nature 107 standout
Sub-graph 1 of 19

Citing Papers

Obesity in adults
2024 Standout
The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
2024 Standout
2 intermediate papers

Works of Aijun Gao being referenced

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
2012 Standout

Author Peers

Author Mechanical Engineering Materials Chemistry PP EDM Molecular Biology Last Decade Papers Cites
Aijun Gao 274 198 133 427 211 44 928
Isabelle Etchart 11 414 12 6 10 544
B. Bhatia 1 21 324 9 564
Allan Jay P. Cardenas 12 108 3 37 23 934
J. M. Bourne 2 37 17 435
Xiufei Gao 3 1 4 167 21 496

All Works

Loading papers...

Rankless by CCL
2026